FDA's independent committee hours away from vote on Moderna booster
The FDA's independent committee is meeting on Thursday and will vote in hours on whether to greenlight the Moderna booster for: people 65 and older; people 18 and older who are at high risk of severe illness because of an underlying health condition; and people 18 and older whose job may put them at greater risk for exposure to the virus.
In introductory remarks Thursday, the FDA's Peter Marks urged the independent panel to "harmonize" its decision with what has already been decided for Pfizer in order to avoid unnecessary confusion for the public.
Pfizer boosters have been authorized for people over 65, all adults with underlying medical conditions and adults whose job puts them at high risk.
The vote is scheduled for about 4:45 p.m.
-ABC News' Sasha Pezenik